Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

CDC Report Shows Gaps in Treatment for High Blood Pressure, Cholesterol

A Centers for Disease Control and Prevention report indicates a significant portion of U.S. adults with high cholesterol and high blood pressure are not receiving adequate treatment. The findings suggest increased vulnerability to heart attack and stroke for many Americans.

06/12/2026 · Mississippi edition

Advertisement

Advertisement

A Centers for Disease Control and Prevention Vital Signs report revealed that a notable percentage of adults in the United States with high cholesterol and high blood pressure are not receiving effective treatment. The data indicates that two-thirds of American adults with high cholesterol are not being treated sufficiently. Similarly, the report found that half of U.S. adults with high blood pressure are undertreated. The CDC suggests this lack of effective management increases the risk of heart attack and stroke among this population.

Healthcare professionals recommend lifestyle changes, such as diet and exercise, and medication to manage high cholesterol and high blood pressure. The CDC encourages individuals to consult with their doctors to determine appropriate treatment plans to mitigate cardiovascular risks.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102873 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Mississippi

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Mississippi

health

Supreme Court Begins Term with Key Arguments, Denies Hundreds of Cases

The Supreme Court began its new term by hearing arguments in two cases on Monday, focusing on climate change liability and veterans' benefits. The court also denied review in hundreds of cases, including disputes over student speech and COVID-19 vaccine mandates. Future arguments will address retirement fund management and federal environmental laws.

Read Story →
health

Florida Reports Largest Continental U.S. Dengue Outbreak in Decades

Florida has recorded its most significant dengue outbreak in decades across the continental United States. Health experts attribute the rise in cases to ongoing mosquito activity and evolving climate patterns. They anticipate a potential increase in localized outbreaks.

Read Story →
health

Trump Administration Finalizes Healthcare Transparency Rule

The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
Scroll for more stories